Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 30/5/2020
SIETES contiene 93014 citas

 1 a 12 de 12 
Presentar resultados
Seleccionar todas
1. Cita con resumen
McCartney M. How the UK regulator became the herbalists' marketeer. BMJ 2014;348:g3194. [Ref.ID 98013]
2. Cita con resumen
Newmaster SG, Grguric M, Shanmughanandhan D, Ramalingam S, Ragupathy S. DNA barcoding detects contamination and substitution in North American herbal products. BMC Med 2013;11:222. [Ref.ID 96274]
3.Enlace a cita original
Tsai HH, Lin HW, Pickard SA, Tsai HY, Mahady GB. Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review. International Journal of Clinical Practice 2012;66:1056-78. [Ref.ID 93669]
4. Cita con resumen
Vannacci A, Lapi F, Baronti R, Gallo E, Gori L, Mugelli A, Firenzuoli F. Too much effectiveness from a herbal drug. Br J Clin Pharmacol 2009;67:473-4. [Ref.ID 85823]
5. Cita con resumen
Silberstein SD. Migraine. Lancet 2004;363:381-91. [Ref.ID 68987]
Bala K. Traditional medicine and public policy. Hai News 2000;113-114:1-9. [Ref.ID 53165]
Chang ZG, Kennedy DT, Holdford DA, Small RE. Pharmacists' knowledge and attitudes toward herbal medicine. Ann Pharmacother 2000;34:710-5. [Ref.ID 51366]
8. Cita con resumen
Vickers A, Zollman C. Herbal medicine. BMJ 1999;319:1050-3. [Ref.ID 47250]
9. Cita con resumen
Morris K. Jury still out on feverfew for migraine prophylaxis. Lancet 1999;353:731. [Ref.ID 43276]
Murch SJ, Simmons C, Saxena PK. Melatonin in feverfew and other medicinal plants. Lancet 1997;350:1598-9. [Ref.ID 36147]
11. Cita con resumen
Murphy JJ, Heptinstall S, Mitchell JRA. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;2:189-92. [Ref.ID 12316]
12. Cita con resumen
Johnson ES, Kadam NP, Hylands DM, Hylands PJ. Efficacy of feverfew as prophylactic treatment of migraine. BMJ 1985;291:569-73. [Ref.ID 8786]
Seleccionar todas
 1 a 12 de 12